Response to "What is the Current Clinical Impact of the CYP2C:TG Haplotype?"

被引：0
|
作者：
Zubiaur, Pablo [1 ]
Leeder, J. Steven [2 ,3 ]
Abad-Santos, Francisco [1 ,4 ]
Gaedigk, Andrea [2 ,3 ]
机构：
[1] Univ Autonoma Madrid UAM, Inst Invest Sanitaria Princesa IP, Inst Teofilo Hernando, Clin Pharmacol Dept,Hosp Univ La Princesa, Madrid, Spain
[2] Childrens Mercy Res Inst CMRI, Div Clin Pharmacol Toxicol & Therapeut Innovat, Kansas City, MO 64108 USA
[3] Univ Missouri Kansas City, Sch Med, Kansas City, MO 64110 USA
[4] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2024年 / 115卷 / 02期
关键词：
D O I：
10.1002/cpt.3093
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：184 / 184
页数：1
相关论文
共 50 条
  • [41] The role of CYP2C in the in vitro bioactivation of the contraceptive steroid desogestrel
    Gentile, DM
    Verhoeven, CHJ
    Shimada, T
    Back, DJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 287 (03): : 975 - 982
  • [42] Retained duplications and deletions of CYP2C genes among primates
    Chaney, Morgan E.
    Piontkivska, Helen
    Tosi, Anthony J.
    MOLECULAR PHYLOGENETICS AND EVOLUTION, 2018, 125 : 204 - 212
  • [43] BIOCHEMISTRY AND MOLECULAR-BIOLOGY OF THE HUMAN CYP2C SUBFAMILY
    GOLDSTEIN, JA
    DEMORAIS, SMF
    PHARMACOGENETICS, 1994, 4 (06): : 285 - 299
  • [44] CYP2C pharmacogenetics and tailor-made therapeutic implications
    Ishizaki, T
    PHARMACOGENETICS - TAILOR-MADE PHARMACOTHERAPY, 2002, 1244 : 1 - 9
  • [45] Expression and distribution of CYP2C enzymes in rat basal ganglia
    Riedl, AG
    Watts, PM
    Douek, DC
    Edwards, RJ
    Boobis, AR
    Rose, S
    Jenner, P
    SYNAPSE, 2000, 38 (04) : 392 - 402
  • [46] Impact of genetic polymorphisms of cytochrome P450 2 C (CYP2C) enzymes on the drug metabolism and design of antidiabetics
    Sun, Hao
    Scott, Dennis O.
    CHEMICO-BIOLOGICAL INTERACTIONS, 2011, 194 (2-3) : 159 - 167
  • [47] CYP2C and CYP2B Mediated Metabolic Activation of Retrorsine in Cyp3a Knockout Mice
    Pang, Xiaoyan
    Tang, Chongzhuang
    Kong, Fandi
    Chen, Meixia
    Chen, Xiaoyan
    CURRENT DRUG METABOLISM, 2020, 21 (13) : 1040 - 1051
  • [48] CYP2C44, a new murine CYP2C that metabolizes arachidonic acid to unique stereospecific products
    DeLozier, TC
    Tsao, CC
    Coulter, SJ
    Foley, J
    Bradbury, JA
    Zeldin, DC
    Goldstein, JA
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 310 (03): : 845 - 854
  • [49] TRANSCRIPTIONAL REGULATION OF HUMAN CYP2C GENES - FUNCTIONAL COMPARISON OF CYP2C9 AND CYP2C18 PROMOTER REGIONS
    IBEANU, GC
    GOLDSTEIN, JA
    BIOCHEMISTRY, 1995, 34 (25) : 8028 - 8036
  • [50] The ontogeny of hepatic CYP3A, CYP2C and CYP2E enzyme activity in conventional pigs
    Millecam, J.
    Devreese, M.
    De Bock, L.
    Van Bocxlaer, J.
    Gasthuys, E.
    De Backer, P.
    Croubels, S.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2015, 38 : 48 - 49
12345